CSS
RCUS icon

Cubist Systematic Strategies’s Arcus Biosciences RCUS Stock Holding History

Cubist Systematic Strategies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-226,337
Closed -$1.84M – 3457
2025
Q2 		$1.84M Sell
226,337
-17,971
-7% -$154K 0.01% 1600
2025
Q1 		$1.92M Buy
244,308
+19,141
+9% +$222K 0.01% 1450
2024
Q4 		$3.35M Buy
225,167
+154,874
+220% +$2.53M 0.02% 1056
2024
Q3 		$1.07M Sell
70,293
-14,170
-17% -$223K 0.01% 1790
2024
Q2 		$1.29M Buy
+84,463
New +$1.36M 0.01% 1592
2023
Q4 		– Sell
-80,031
Closed -$1.44M – 4009
2023
Q3 		$1.44M Buy
80,031
+79,842
+42,244% +$1.6M 0.01% 1613
2023
Q2 		$3.84K Sell
189
-67,841
-100% -$1.29M ﹤0.01% 3328
2023
Q1 		$1.24M Sell
68,030
-40,874
-38% -$781K 0.01% 2007
2022
Q4 		$2.25M Buy
108,904
+36,430
+50% +$1M 0.01% 1759
2022
Q3 		$1.9M Sell
72,474
-43,708
-38% -$1.16M 0.01% 2062
2022
Q2 		$2.94M Buy
116,182
+67,294
+138% +$1.65M 0.02% 1487
2022
Q1 		$1.54M Sell
48,888
-17,464
-26% -$585K 0.01% 1699
2021
Q4 		$2.69M Buy
66,352
+50,261
+312% +$1.95M 0.03% 1119
2021
Q3 		$561K Sell
16,091
-13,266
-45% -$413K 0.01% 1952
2021
Q2 		$806K Buy
29,357
+11,732
+67% +$335K 0.01% 1717
2021
Q1 		$495K Sell
17,625
-4,625
-21% -$161K 0.01% 1968
2020
Q4 		$578K Sell
22,250
-14,245
-39% -$345K 0.01% 1692
2020
Q3 		$626K Sell
36,495
-32,381
-47% -$723K 0.01% 1607
2020
Q2 		$1.7M Buy
+68,876
New +$1.86M 0.03% 893
2019
Q3 		– Sell
-20,494
Closed -$163K – 2419
2019
Q2 		$163K Buy
+20,494
New +$205K ﹤0.01% 2130
2018
Q3 		– Sell
-10,009
Closed -$123K – 2044
2018
Q2 		$123K Buy
10,009
+1,113
+13% +$17.5K 0.01% 1475
2018
Q1 		$137K Buy
+8,896
New +$148K 0.01% 1528

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's RCUS Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Arcus Biosciences (RCUS) in Q3 2025, closing a stake of 226,337 shares — an estimated $1.84M sold.

Cubist Systematic Strategies first reported a position in RCUS in Q1 2018 and held it in 22 quarters. The position peaked at $3.35M in Q4 2024. 190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Arcus Biosciences position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 226,337 Arcus Biosciences shares in Q3 2025, an estimated $1.84M.
  • Cubist Systematic Strategies first reported a position in Arcus Biosciences in Q1 2018 and held it in 22 quarters.
  • Cubist Systematic Strategies's Arcus Biosciences position peaked at $3.35M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.